Huang et al. suggested that down-regulating S100A2 was able to inhibit the Wnt/β-Catenin signaling pathway, thus reliving the epithelial-mesenchymal transition (EMT) in pulmonary fibrosis (Huang et al., 2021). The gene discussed is S100A2; the disease is pulmonary fibrosis.